Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.
about
Extended-spectrum beta-lactamases: a clinical updateExtended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatThree decades of beta-lactamase inhibitorsThe structural bases of antibiotic resistance in the clinically derived mutant beta-lactamases TEM-30, TEM-32, and TEM-34Genetic and Structural Characterization of an L201P Global Suppressor Substitution in TEM-1 β-LactamaseStructural and Biochemical Evidence That a TEM-1 -Lactamase N170G Active Site Mutant Acts via Substrate-assisted CatalysisAnalysis of the Binding Forces Driving the Tight Interactions between -Lactamase Inhibitory Protein-II (BLIP-II) and Class A -LactamasesTargeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid DerivativeComplete nucleotide sequence of CTX-M-15-plasmids from clinical Escherichia coli isolates: insertional events of transposons and insertion sequencesNetwork models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectoriesAntimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance.Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.Multidrug evolutionary strategies to reverse antibiotic resistance.Epidemiology of infections due to extended-spectrum Beta-lactamase-producing bacteria in a pediatric intensive care unit.Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.Kinetic study of two novel enantiomeric tricyclic beta-lactams which efficiently inactivate class C beta-lactamases.TEM-80, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Enterobacter cloacaeTEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).Fluorescent TEM-1 β-lactamase with wild-type activity as a rapid drug sensor for in vitro drug screening.TEM-103/IRT-28 beta-lactamase, a new TEM variant produced by Escherichia coli BM4511.The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in KuwaitNew beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.Overcoming antimicrobial resistance by targeting resistance mechanisms.Ex vivo pharmacodynamics of amoxicillin-clavulanate against beta-lactamase-producing Escherichia coli in a yucatan miniature pig model that mimics human pharmacokinetics.Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.Structural consequences of the inhibitor-resistant Ser130Gly substitution in TEM beta-lactamaseMultiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.Integration of a transposon Tn1-encoded inhibitor-resistant beta-lactamase gene, bla(TEM-67) from Proteus mirabilis, into the Escherichia coli chromosome.CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.Growing group of extended-spectrum beta-lactamases: the CTX-M enzymesMolecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.The class A β-lactamase FTU-1 is native to Francisella tularensis.Virulence factors and TEM-type β-lactamases produced by two isolates of an epidemic Klebsiella pneumoniae strain.Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.Class A carbapenemase FPH-1 from Francisella philomiragiaThe Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
P2860
Q24534999-C53B15B3-FE4B-4420-9DE2-2CC75071B138Q24550671-556A820A-2486-4F46-8B2F-147981675E14Q24646623-B8441697-F1E0-4F61-AF34-7DB9134DFFC3Q27639159-434D7B0C-CF59-449A-ADC6-8CAAD46422EEQ27652316-D998B3A3-C8A3-43F3-A245-1771FB107013Q27657721-70104020-C205-43F2-8FB7-8EA92E706734Q27670891-A0866CCA-847E-43C1-9002-5144CC9A7FB9Q27684016-38BC9496-93E1-462A-AF27-871FAD58760FQ28474528-42C501B8-E674-4FFA-AF28-67D5A20DB782Q28477196-1BF5B2CC-6CE5-4CC3-8F36-648DA5C5270BQ30790128-EA55802A-B82E-4B9D-B73F-E79884C07574Q33613797-1BD02A2B-0BD9-44CC-8D00-657E91B5F8CCQ33871101-55C7C9A7-BFF4-4DD3-BAC2-7282D2BC5664Q33886817-34C83490-CA6D-402A-B166-DCD53CE6F919Q33971097-2E476C26-7BBF-4221-9D39-9B89B580510BQ33973139-C4B1A161-A9D9-42FC-9EFA-6DD2A3488751Q33980735-F3C92FBB-DF58-4FC6-98EF-47E958A4B60BQ33982670-C6B0828D-3C60-48C4-9616-88A9A18F1A08Q34106908-0C845559-4464-4B88-98D6-FFBFC9A619A3Q34123641-016485CA-BDD7-447B-8D7D-486ACAB3CF4DQ34139889-27BA70DB-E7EA-4A79-B7CA-7E024F6E47FAQ34142071-2BF99F77-5F03-41ED-A3C8-FF3A65C79987Q34157129-17499AB2-D039-46B8-825C-7D7A1E6A4B42Q34192597-9BD8999F-3153-4910-8731-2958444059B4Q34211132-DF7A073B-3073-4AD9-A1F3-75CDBABE5D61Q34252545-4F6DBFDA-3F61-47D3-B9F0-134C7B8D7594Q34352214-45316340-0391-4934-A3FD-A217C65A6D1CQ34406813-03B40817-DFD1-4277-9847-94AEE424988AQ34548635-103C9694-2AB7-458C-94D7-D0DE5E3B54F3Q34594475-49D2D59D-81A6-4535-8F37-D557280AECCEQ34720517-A9B74DA5-D246-4C18-ACC3-63A317FD2F77Q34721603-6F86BAF2-2809-4CA1-A114-07511C240DCDQ35006613-5D89F9F5-9255-4EA1-B2DC-8E2647A1C904Q35598386-15C14DD2-1813-4A98-9E3A-93B1B50F65FEQ35689231-46FF70F3-D1FA-4A74-ABCB-6B46DE3B5BA8Q35689234-3976A024-2018-44CE-8475-1736ACB03A52Q35758897-0F097FC1-BDD8-4E3E-B1D3-878AFA6B3D9DQ35906971-79325EC2-D5C4-4E56-BDAD-A502E96B02F9Q36018786-7112CA9A-5F1D-43B6-A3D1-73B1C6D7FCC9Q36593875-2DFAED7E-A34C-4E2F-82CF-328047AD4631
P2860
Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Inhibitor-resistant TEM beta-l ...... d biochemical characteristics.
@ast
Inhibitor-resistant TEM beta-l ...... d biochemical characteristics.
@en
type
label
Inhibitor-resistant TEM beta-l ...... d biochemical characteristics.
@ast
Inhibitor-resistant TEM beta-l ...... d biochemical characteristics.
@en
prefLabel
Inhibitor-resistant TEM beta-l ...... d biochemical characteristics.
@ast
Inhibitor-resistant TEM beta-l ...... d biochemical characteristics.
@en
P2093
P2860
P356
P1476
Inhibitor-resistant TEM beta-l ...... d biochemical characteristics.
@en
P2093
P2860
P304
P356
10.1093/JAC/43.4.447
P407
P577
1999-04-01T00:00:00Z